Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.

Correa RJM, Ahmad B, Warner A, Johnson C, MacKenzie MJ, Pautler SE, Bauman GS, Rodrigues GB, Louie AV.

Radiat Oncol. 2018 Mar 20;13(1):47. doi: 10.1186/s13014-018-0992-3.

2.

Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based?

Corkum MT, Liu W, Palma DA, Bauman GS, Dinniwell RE, Warner A, Mishra MV, Louie AV.

Radiat Oncol. 2018 Mar 15;13(1):43. doi: 10.1186/s13014-018-0988-z.

3.

Prediction of radiation necrosis in a rodent model using magnetic resonance imaging apparent transverse relaxation ([Formula: see text]).

Belliveau JG, Jensen MD, Stewart JMP, Solovey I, Klassen LM, Bauman GS, Menon RS.

Phys Med Biol. 2018 Jan 26;63(3):035010. doi: 10.1088/1361-6560/aaa034.

PMID:
29372691
4.

Signal enhancement ratio imaging of the lung parenchyma with ultra-fast steady-state free precession MRI at 1.5T.

Pusterla O, Sommer G, Santini F, Wiese M, Lardinois D, Tamm M, Bremerich J, Bauman G, Bieri O.

J Magn Reson Imaging. 2018 Jul;48(1):48-57. doi: 10.1002/jmri.25928. Epub 2018 Jan 3.

PMID:
29297607
5.

Prediction of radiation necrosis in a rodent model using magnetic resonance imaging apparent transverse relaxation (R2*).

Belliveau JG, Jensen MD, Stewart JMP, Solovey I, Klassen ML, Bauman GS, Menon RS.

Phys Med Biol. 2017 Dec 8. doi: 10.1088/1361-6560/aaa034. [Epub ahead of print]

PMID:
29219117
6.

Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease.

Nyilas S, Bauman G, Sommer G, Stranzinger E, Pusterla O, Frey U, Korten I, Singer F, Casaulta C, Bieri O, Latzin P.

Eur Respir J. 2017 Dec 7;50(6). pii: 1701464. doi: 10.1183/13993003.01464-2017. Print 2017 Dec.

PMID:
29217601
7.

Apparent transverse relaxation (R2∗) on MRI as a method to differentiate treatment effect (pseudoprogression) versus progressive disease in chemoradiation for malignant glioma.

Belliveau JG, Bauman GS, Macdonald D, Macdonald M, Klassen LM, Menon RS.

J Med Imaging Radiat Oncol. 2018 Apr;62(2):224-231. doi: 10.1111/1754-9485.12694. Epub 2017 Nov 30.

PMID:
29193849
8.

Initial Investigation into Microbleeds and White Matter Signal Changes following Radiotherapy for Low-Grade and Benign Brain Tumors Using Ultra-High-Field MRI Techniques.

Belliveau JG, Bauman GS, Tay KY, Ho D, Menon RS.

AJNR Am J Neuroradiol. 2017 Dec;38(12):2251-2256. doi: 10.3174/ajnr.A5395. Epub 2017 Sep 28.

PMID:
28970242
9.

The "Dirty Harry" Approach.

Bauman G, Winquist E.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):8. doi: 10.1016/j.ijrobp.2017.05.036. Epub 2017 Aug 7. No abstract available.

PMID:
28816166
10.

Accuracy and variability of high-dose-rate prostate brachytherapy needle tip localization using live two-dimensional and sagittally reconstructed three-dimensional ultrasound.

Hrinivich WT, Hoover DA, Surry K, Edirisinghe C, Velker V, Bauman G, D'Souza D, Fenster A, Wong E.

Brachytherapy. 2017 Sep - Oct;16(5):1035-1043. doi: 10.1016/j.brachy.2017.06.008. Epub 2017 Jul 29.

PMID:
28764882
11.

68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.

von Eyben FE, Picchio M, von Eyben R, Rhee H, Bauman G.

Eur Urol Focus. 2016 Nov 15. pii: S2405-4569(16)30160-2. doi: 10.1016/j.euf.2016.11.002. [Epub ahead of print] Review.

12.

[18F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.

Bauman G, Martin P, Thiessen JD, Taylor R, Moussa M, Gaed M, Rachinsky I, Kassam Z, Chin J, Pautler S, Lee TY, Valliant JF, Ward A.

Eur Urol Focus. 2016 Oct 26. pii: S2405-4569(16)30147-X. doi: 10.1016/j.euf.2016.10.002. [Epub ahead of print]

PMID:
28753797
13.

Lessons learned from reirradiation of recurrent skull base meningioma: A case report and review of the literature.

Pritchard AG, Nguyen TK, Bauman GS.

Adv Radiat Oncol. 2017 Jan 18;2(1):1-5. doi: 10.1016/j.adro.2017.01.002. eCollection 2017 Jan-Mar. No abstract available.

14.

Extreme hypofractionation for high-risk prostate cancer: Dosimetric correlations with rectal bleeding.

Bauman G, Chen J, Rodrigues G, Davidson M, Warner A, Loblaw A.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e457-e462. doi: 10.1016/j.prro.2017.06.002. Epub 2017 Jun 9.

PMID:
28734642
15.

Dynamic and steady-state oxygen-dependent lung relaxometry using inversion recovery ultra-fast steady-state free precession imaging at 1.5 T.

Bauman G, Pusterla O, Santini F, Bieri O.

Magn Reson Med. 2018 Feb;79(2):839-845. doi: 10.1002/mrm.26739. Epub 2017 May 18.

PMID:
28520198
16.

Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.

McPherson VA, Rodrigues G, Bauman G, Winquist E, Chin J, Izawa J, Potvin K, Ernst S, Venkatesan V, Sexton T, Ahmad B, Power N.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E64-E65. doi: 10.5489/cuaj.4476. Epub 2017 Feb 20. No abstract available.

17.

Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.

McPherson VA, Rodrigues G, Bauman G, Winquist E, Chin J, Izawa J, Potvin K, Ernst S, Venkatesan V, Sexton T, Ahmad B, Power N.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):24-30. doi: 10.5489/cuaj.4008.

18.

Accuracy Validation of an Automated Method for Prostate Segmentation in Magnetic Resonance Imaging.

Shahedi M, Cool DW, Bauman GS, Bastian-Jordan M, Fenster A, Ward AD.

J Digit Imaging. 2017 Dec;30(6):782-795. doi: 10.1007/s10278-017-9964-7.

PMID:
28342043
19.

Three-dimensional oxygen-enhanced MRI of the human lung at 1.5T with ultra-fast balanced steady-state free precession.

Pusterla O, Bauman G, Bieri O.

Magn Reson Med. 2018 Jan;79(1):246-255. doi: 10.1002/mrm.26665. Epub 2017 Mar 24.

PMID:
28337782
20.

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

Catton CN, Lukka H, Gu CS, Martin JM, Supiot S, Chung PWM, Bauman GS, Bahary JP, Ahmed S, Cheung P, Tai KH, Wu JS, Parliament MB, Tsakiridis T, Corbett TB, Tang C, Dayes IS, Warde P, Craig TK, Julian JA, Levine MN.

J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15.

PMID:
28296582
21.

Optimization of brain metastases radiotherapy with TomoHDA.

Yartsev S, Bauman G.

Med Dosim. 2017 Spring;42(1):53-56. doi: 10.1016/j.meddos.2016.11.003. Epub 2017 Jan 24.

PMID:
28126476
22.

Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.

Qu XM, Mishra MV, Bauman GS, Slotman B, Mehta M, Gondi V, Louie AV.

Radiother Oncol. 2017 Mar;122(3):411-415. doi: 10.1016/j.radonc.2017.01.005. Epub 2017 Jan 18.

PMID:
28109544
23.

Postediting prostate magnetic resonance imaging segmentation consistency and operator time using manual and computer-assisted segmentation: multiobserver study.

Shahedi M, Cool DW, Romagnoli C, Bauman GS, Bastian-Jordan M, Rodrigues G, Ahmad B, Lock M, Fenster A, Ward AD.

J Med Imaging (Bellingham). 2016 Oct;3(4):046002. Epub 2016 Nov 7.

24.

Rapid 3D in vivo 1H human lung respiratory imaging at 1.5 T using ultra-fast balanced steady-state free precession.

Pusterla O, Bauman G, Wielpütz MO, Nyilas S, Latzin P, Heussel CP, Bieri O.

Magn Reson Med. 2017 Sep;78(3):1059-1069. doi: 10.1002/mrm.26503. Epub 2016 Oct 23.

PMID:
27774645
25.

Pulmonary relaxometry with inversion recovery ultra-fast steady-state free precession at 1.5T.

Bauman G, Santini F, Pusterla O, Bieri O.

Magn Reson Med. 2017 Jan;77(1):74-82. doi: 10.1002/mrm.26490. Epub 2016 Oct 19.

PMID:
27759935
26.

Target margins in radiotherapy of prostate cancer.

Yartsev S, Bauman G.

Br J Radiol. 2016 Nov;89(1067):20160312. Epub 2016 Jul 20. Review.

27.

Searching for wisdom in oncology care: A scoping review.

Butlin H, Kinsella EA, Garcia C, Bauman G.

Palliat Support Care. 2017 Jun;15(3):384-400. doi: 10.1017/S1478951516000675. Epub 2016 Sep 26. Review.

PMID:
27666083
28.

Detecting tumor progression in glioma: current standards and new techniques.

Belliveau JG, Bauman G, Macdonald DR.

Expert Rev Anticancer Ther. 2016 Oct 8:1-12. [Epub ahead of print]

PMID:
27661768
29.

Patient- and family-centered care: a qualitative exploration of oncologist perspectives.

Nguyen TK, Bauman GS, Watling CJ, Hahn K.

Support Care Cancer. 2017 Jan;25(1):213-219. Epub 2016 Sep 11.

PMID:
27614869
30.

Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images.

Eilaghi A, Yeung T, d'Esterre C, Bauman G, Yartsev S, Easaw J, Fainardi E, Lee TY, Frayne R.

Biomark Cancer. 2016 Jul 3;8(Suppl 2):47-59. doi: 10.4137/BIC.S31801. eCollection 2016. Review.

31.

Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.

Gibson E, Bauman GS, Romagnoli C, Cool DW, Bastian-Jordan M, Kassam Z, Gaed M, Moussa M, Gómez JA, Pautler SE, Chin JL, Crukley C, Haider MA, Fenster A, Ward AD.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):188-96. doi: 10.1016/j.ijrobp.2016.04.018. Epub 2016 Apr 21.

PMID:
27375167
32.

Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.

Eapen LJ, Jones E, Kassouf W, Lambert C, Morgan SC, Moussa M, Nam R, Parliament M, Russell L, Saad F, Siemens DR, Souhami L, Szumacher E, Tyldesley S, Xu Y, Zbieranowski I, Breau RH, Belanger E, Black P, Estey E, Bowan J, Bora B, Brundage M, Chung P, Fleshner N, Evans A, Bauman G, Izawa J, Davidson C, Brimo F.

Can Urol Assoc J. 2016 Mar-Apr;10(3-4):90-4. doi: 10.5489/cuaj.3456.

33.

Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.

Siddiqui KM, Billia M, Al-Zahrani A, Williams A, Goodman C, Arifin A, Violette P, Bauman G, Chin JL.

J Urol. 2016 Oct;196(4):1105-11. doi: 10.1016/j.juro.2016.04.080. Epub 2016 May 6.

PMID:
27157372
34.

Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.

Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, Dar AR, Lambert C, Pond G, Stitt L, Tay KY, Rodrigues G.

J Neurooncol. 2016 Jul;128(3):431-6. doi: 10.1007/s11060-016-2128-7. Epub 2016 Apr 15.

PMID:
27084705
35.

Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia.

Qi Q, Yeung TP, Lee TY, Bauman G, Crukley C, Morrison L, Hoffman L, Yartsev S.

PLoS One. 2016 Apr 14;11(4):e0153569. doi: 10.1371/journal.pone.0153569. eCollection 2016.

36.

[MRI methods for pulmonary ventilation and perfusion imaging].

Sommer G, Bauman G.

Radiologe. 2016 Feb;56(2):106-12. doi: 10.1007/s00117-015-0074-6. Review. German.

PMID:
26814473
37.

Matrix pencil decomposition of time-resolved proton MRI for robust and improved assessment of pulmonary ventilation and perfusion.

Bauman G, Bieri O.

Magn Reson Med. 2017 Jan;77(1):336-342. doi: 10.1002/mrm.26096. Epub 2016 Jan 12.

PMID:
26757102
38.

In Reply to Kishan et al.

Bauman G, Rodrigues G, Chen J, Loblaw A.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1163. doi: 10.1016/j.ijrobp.2015.08.016. Epub 2015 Nov 11. No abstract available.

PMID:
26581153
39.

CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.

Caine C, Deshmukh S, Gondi V, Mehta M, Tomé W, Corn BW, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Raben A, Shi W, Wendland M, Kachnic L.

J Neurooncol. 2016 Jan;126(2):327-36. doi: 10.1007/s11060-015-1971-2. Epub 2015 Oct 28.

40.

Pulmonary perfusion imaging: Qualitative comparison of TCIR MRI and SPECT/CT in porcine lung.

Gaass T, Bauman G, Biederer J, Hintze C, Schneider M, Dinkel J.

Eur J Radiol. 2015 Dec;84(12):2646-53. doi: 10.1016/j.ejrad.2015.08.017. Epub 2015 Sep 2.

PMID:
26481482
41.

Choosing Wisely? "It's Complicated!".

Bauman G.

Pract Radiat Oncol. 2016 Mar-Apr;6(2):71-3. doi: 10.1016/j.prro.2015.06.003. Epub 2015 Oct 5. No abstract available.

PMID:
26437834
42.

Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging.

Yeung TP, Wang Y, He W, Urbini B, Gafà R, Ulazzi L, Yartsev S, Bauman G, Lee TY, Fainardi E; Project of Emilia-Romagna Region on Neuro-Oncology (PERNO) Study Group.

J Neurooncol. 2015 Oct;125(1):223-4. doi: 10.1007/s11060-015-1946-3. No abstract available.

PMID:
26419781
43.

Reversed half-echo stack-of-stars TrueFISP (TrueSTAR).

Bauman G, Bieri O.

Magn Reson Med. 2016 Aug;76(2):583-90. doi: 10.1002/mrm.25880. Epub 2015 Sep 2.

PMID:
26332134
44.

The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy.

Lowes LE, Lock M, Rodrigues G, D'Souza D, Bauman G, Ahmad B, Venkatesan V, Allan AL, Sexton T.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):358-64. doi: 10.1038/pcan.2015.36. Epub 2015 Aug 4.

45.

Ultra-fast Steady-State Free Precession Pulse Sequence for Fourier Decomposition Pulmonary MRI.

Bauman G, Pusterla O, Bieri O.

Magn Reson Med. 2016 Apr;75(4):1647-53. doi: 10.1002/mrm.25697. Epub 2015 May 12.

PMID:
25965158
46.

A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer.

Bauman G, Ferguson M, Lock M, Chen J, Ahmad B, Venkatesan VM, Sexton T, D'Souza D, Loblaw A, Warner A, Rodrigues G.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):856-62. doi: 10.1016/j.ijrobp.2015.02.046. Epub 2015 Apr 30.

PMID:
25936597
47.

Survival prediction in high-grade gliomas using CT perfusion imaging.

Yeung TP, Wang Y, He W, Urbini B, Gafà R, Ulazzi L, Yartsev S, Bauman G, Lee TY, Fainardi E; Project of Emilia-Romagna Region on Neuro-Oncology Study Group.

J Neurooncol. 2015 May;123(1):93-102. doi: 10.1007/s11060-015-1766-5. Epub 2015 Apr 11. Erratum in: J Neurooncol. 2015 Oct;125(1):223-4.

PMID:
25862005
48.

Dynamic perfusion CT in brain tumors.

Yeung TP, Bauman G, Yartsev S, Fainardi E, Macdonald D, Lee TY.

Eur J Radiol. 2015 Dec;84(12):2386-92. doi: 10.1016/j.ejrad.2015.02.012. Epub 2015 Feb 23. Review.

PMID:
25796424
49.

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM.

J Clin Oncol. 2015 Feb 1;33(4):332-9. doi: 10.1200/JCO.2014.58.0662. Epub 2014 Dec 22.

50.

Unshielded asymmetric transmit-only and endorectal receive-only radiofrequency coil for (23) Na MRI of the prostate at 3 tesla.

Farag A, Peterson JC, Szekeres T, Bauman G, Chin J, Romagnoli C, Bartha R, Scholl TJ.

J Magn Reson Imaging. 2015 Aug;42(2):436-45. doi: 10.1002/jmri.24798. Epub 2014 Nov 19.

PMID:
25407847

Supplemental Content

Loading ...
Support Center